Kroger Health has announced a collaboration with Gauss, to offer the latter’s smartphone-enabled Covid-19 at-home rapid antigen test kit to patients across the US. The move expands the company’s existing portfolio of employer-focused and in-clinic Covid-19 testing solutions.
XPhyto Therapeutics, a bioscience accelerator, and its exclusive German diagnostics development partner, 3a-diagnostics, have completed all the procedures required for a European regulatory application for the Covid-ID Lab test system. 3a expects to receive device manufacturing and CE-IVD approvals by late February and early March, respectively.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Avricore Health has signed a Letter of Intent with Avrok Laboratories, a CLIA certified laboratory in California, to offer real-time Covid-19 screening to travellers in Canada, USA, Mexico, and the Caribbean. The move was initiated by significant interest expressed by consumers, airlines, and the government alike, who felt the need for a reliable programme to test travellers and resume international travel. LifeLabs and
LifeLabs and Multiplex Genomics have announced a strategic partnership to expand testing capacity and Covid-19 variants in Canada. The companies are estimating that together they will be able to evaluate 20,000 Covid-19 samples every day, with plans to achieve testing 50,000 samples per day by mid-2021. In addition, every positive sample is expected to be sequenced and characterised to assign it to a variant.
